What is the strategic rationale behind the proposed merger with Computer Motion, Inc.?

The merger with Computer Motion is driven by several strategic factors: combining complementary technologies to strengthen the company's position in robotic surgery, eliminating costly and time-consuming patent litigation between the two companies, and achieving significant annual pre-tax cost savings of approximately $18 million through operational synergies and workforce reductions. The merger aims to create a dominant entity in the field.

What are the key financial highlights for the fiscal year ended December 31, 2002?

For the year ended December 31, 2002, Intuitive Surgical reported sales of $72.0 million, a 39% increase from the prior year, primarily due to an increase in da Vinci Surgical System sales (60 systems sold) and substantial growth in recurring instrument, accessory, and service revenue (up 116%). Gross profit margin improved to 52% from 45% in the previous year. However, the company continued to report a net loss of $18.4 million.

What are the main risks and challenges highlighted by Intuitive Surgical in this filing?

Key risks include intense competition from established surgical techniques and other companies developing minimally invasive technologies, potential product liability claims, reliance on third-party reimbursement from government and insurance companies, challenges in manufacturing scale-up and maintaining regulatory compliance (FDA), the long and uncertain sales cycle for major capital equipment, and the significant risks and uncertainties associated with ongoing intellectual property litigation, particularly with Computer Motion and Brookhill-Wilk 1, LLC. The success of the Computer Motion merger also presents integration risks.

How does Intuitive Surgical generate revenue, and what is the trend for recurring revenue?

The majority of Intuitive Surgical's revenue comes from the sale of the da Vinci Surgical System, which are high-value capital items. However, the company is also seeing significant growth in recurring revenue from the sale of disposable EndoWrist instruments, accessories, and ongoing service contracts for installed systems. Recurring revenue as a percentage of total revenue grew from 12% in 2000 to 21% in 2002, indicating a strengthening of its recurring revenue stream.

ISRG 10-K FY2002 Annual Report — Revenue, Net Income, EPS

Summary

Intuitive Surgical, Inc. (ISRG) is a medical device company founded in 1995, specializing in robotic-assisted minimally invasive surgery. In its 2003 10-K filing, the company highlights the development and market introduction of its da Vinci Surgical System, a third-generation surgical platform designed to offer the precision and visualization of open surgery while enabling surgeons to operate through small incisions, akin to minimally invasive surgery (MIS). The company has secured FDA clearance for various procedures, including general surgery, urologic surgery (prostatectomy), and cardiothoracic procedures, and has sold 149 da Vinci systems by the end of 2002. A significant development discussed is the proposed merger with Computer Motion, Inc. This merger is presented as a strategic move to combine complementary technologies, dismiss ongoing patent litigation between the two companies, and achieve substantial cost synergies. The merger is anticipated to result in the combined entity holding a dominant position in the robotic surgery market, with Intuitive Surgical stockholders expected to retain a majority ownership post-merger. The company emphasizes its ongoing strategy to establish Intuitive surgery as the standard for complex procedures through focused marketing, surgeon training, and new procedure development, aiming to drive adoption and expand its market share.

Key Highlights

1The company's core product is the da Vinci Surgical System, a robotic-assisted surgical platform designed to enhance surgeon capabilities and patient outcomes by combining the benefits of open surgery and minimally invasive surgery (MIS).
2As of December 31, 2002, Intuitive Surgical had sold 149 da Vinci Surgical Systems and achieved FDA clearance for several key surgical procedures.
3A proposed merger with competitor Computer Motion, Inc. was announced, aiming to consolidate market leadership, resolve intellectual property disputes, and achieve significant cost synergies of approximately $18 million annually.
4Revenue for the year ended December 31, 2002, was $72.0 million, representing a 39% increase over the previous year, driven by system sales and growth in recurring instrument, accessory, and service revenue.
5The company continues to invest heavily in research and development to enhance its product offerings and explore new clinical applications.
6Intuitive Surgical faces significant legal challenges, including ongoing patent litigation with Brookhill-Wilk 1, LLC and Computer Motion, Inc., which pose risks to its competitive position and product sales.
7The company relies on a robust intellectual property strategy, including patents and exclusive licenses from institutions like SRI International and IBM, to protect its technological advancements.

INTUITIVE SURGICAL INC Annual Report (Amendment), Year Ended Dec 31, 2002

Summary

Key Highlights

Frequently Asked Questions